BCL7A blocking peptide

BCL7A blocking peptide
SKU
GTX89978-PEP-100
Packaging Unit
100 μg
Manufacturer
GeneTex

Availability: loading...
Price is loading...
Species: Human

Specificity/Sensitivity: The peptide was used in the production of GTX89978.

Form: Lyophilized powder

Buffer (with preservative): Reconstitute with 200μl distilled water to obtain a 0.5mg/ml peptide solution. Lyophilized from 5% (v/v) acetonitrile/H₂O, no preservative.

Background: This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Region Sequence: C-MKLEASQQNSEEM

Full Name: B-cell CLL/lymphoma 7A
More Information
SKU GTX89978-PEP-100
Manufacturer GeneTex
Manufacturer SKU GTX89978-PEP-100
Package Unit 100 μg
Quantity Unit STK
Human Gene ID 605
Product information (PDF) Download
MSDS (PDF) Download